2 news items
Sinclair Wins 16 Telly Awards
SBGI
22 May 24
& Safety
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
ABNB
ADV
AGS
9 May 24
initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, demonstrating a favorable safety profile and confirmed anti-cancer
- Prev
- 1
- Next